New Zealand markets closed

Labcorp Holdings Inc. (LH)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
210.59-2.54 (-1.19%)
At close: 04:00PM EDT
210.49 -0.10 (-0.05%)
After hours: 07:51PM EDT

Labcorp Holdings Inc.

358 South Main Street
Burlington, NC 27215
United States
336 229 1127

IndustryDiagnostics & Research
Full-time employees67,000

Key executives

NameTitlePayExercisedYear born
Mr. Adam H. SchechterPresident, CEO & Chairman4.66MN/A1965
Mr. Glenn A. EisenbergCFO & Executive VP1.87MN/A1961
Mr. Mark S. SchroederExecutive VP, President of Diagnostics Laboratories & COO1.43M129.25k1961
Dr. Brian J. Caveney J.D., M.D., M.P.H.EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer1.3MN/A1974
Ms. Anita Z. GrahamExecutive VP & Chief Human Resources Officer1.35MN/A1971
Mr. Peter J. WilkinsonSenior VP & Chief Accounting OfficerN/AN/A1972
Mr. Lance V. BerberianExecutive VP and Chief Information & Technology Officer876.62kN/A1963
Christin O'DonnellVice President of Investor RelationsN/AN/AN/A
Ms. Sandra D. van der VaartExecutive VP, Chief Legal Officer & Corporate SecretaryN/AN/A1960
Ms. Amy B. SummyExecutive VP & Chief Marketing OfficerN/AN/A1967
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Labcorp Holdings Inc. operates as a laboratory services company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS). The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C and vitamin D, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs), including health fairs, on-site and at-home testing, vaccinations, and health screenings. In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; and drug development, medical device, and companion diagnostic development solutions from early-stage research to clinical development, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company is headquartered in Burlington, North Carolina.

Corporate governance

Labcorp Holdings Inc.’s ISS governance QualityScore as of 1 May 2024 is 3. The pillar scores are Audit: 6; Board: 7; Shareholder rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.